---
title: >-
  Medication Use and Comorbidities Among Elderly as Compared to Younger Patients
  with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)
description: >-
  Explore this publication on real-world evidence: Medication Use and
  Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory
  Bowel…
date: '2020-01-01'
author: Julie M. Crawford
category: Publications
tags:
  - 'Yes'
  - R&D
  - Atrium Health
  - University of Chicago
  - Gastroenterology
  - Care
  - ACG
  - University of North Carolina at Chapel Hill
  - Health System Partner
  - Poster Presentation
  - University of Wisconsin
  - IBD
  - Cleveland Clinic
  - Mount Sinai
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/feat-yes/medication-use-and-comorbidities-among-elderly-as-compared/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: medication-use-and-comorbidities-among-elderly-as-compared
id: 1iEz5vzpD545jvzSJng8YE
contentType: article
---

## Challenge

This is the ACG 2019 poster version of the elderly IBD medication use study (Row 7 manuscript, Row 21 DDW oral). Earliest conference presentation characterizing age-related medication use disparities in the TARGET-IBD cohort, with elderly patients receiving significantly more aminosalicylate monotherapy.

## Solution

The TARGET-IBD registry was analyzed to compare medication use distributions across age categories at the ACG 2019 annual meeting, providing the first large-scale real-world characterization of this age-related treatment pattern gap.

## Impact

Initial ACG 2019 dissemination of the elderly IBD medication use findings establishes the evidence foundation for subsequent publications and prescriber education on age-related treatment disparities, supporting the case for guideline revision regarding biologic access in elderly IBD patients.

## Use Cases / Links

First dissemination of elderly IBD medication use disparities for age-inclusive treatment guideline development, Initial real-world evidence of aminosalicylate overuse in elderly IBD for prescriber education, Evidence foundation for age-stratified IBD treatment advocacy and inclusive trial design